# Employers & Consultants 06.3.26 [**3 ways the modern prescription experience is starting to look more like modern commerce**](/content/insights/3-ways-the-modern-prescription-experience-is-starting-to-look-more-like-modern-commerce/index.html) New direct-to-patient prescription models are emerging as consumers demand the same convenience, transparency, and digital control they experience… [Read More](/content/insights/3-ways-the-modern-prescription-experience-is-starting-to-look-more-like-modern-commerce/index.html) 05.6.26 [Press Release](/content/news-type/press-release/index.html) [**Prescryptive Helps Power LillyDirect®, Supporting Direct-to-Patient Access**](/content/prescryptive-helps-power-lillydirect-supporting-direct-to-patient-access/index.html) Redmond, WA – May 6, 2026 – Prescryptive Health today announced it serves as a technology platform helping to… [Read More](/content/prescryptive-helps-power-lillydirect-supporting-direct-to-patient-access/index.html) 04.14.26 [In the News](/content/news-type/in-the-news/index.html) [**Chief Executive Officer Chris Blackley on the healthcare leadership operating system**](/content/chief-executive-officer-chris-blackley-on-the-healthcare-leadership-operating-system/index.html) “A huge challenge for healthcare leaders is that they are being asked to sustain high performance inside systems… [Read More](/content/chief-executive-officer-chris-blackley-on-the-healthcare-leadership-operating-system/index.html) 04.14.26 [In the News](/content/news-type/in-the-news/index.html) [**GLP-1 pills are here: What does it mean for employers?**](/content/glp-1-pills-are-here-what-does-it-mean-for-employers/index.html) Will GLP-1 pills change how employers approach coverage? It’s an important question, but the answer isn't so straightforward. [Read More](/content/glp-1-pills-are-here-what-does-it-mean-for-employers/index.html) 03.25.26 [In the News](/content/news-type/in-the-news/index.html) [**As Ozempic costs fall, demand for weight-loss drugs is set to surge**](/content/as-ozempic-costs-fall-demand-for-glp-1-weight-loss-drugs-is-set-to-surge/index.html) On the surface, lower GLP-1 prices should make these therapies easier to manage. But as Rae McMahan, SVP… [Read More](/content/as-ozempic-costs-fall-demand-for-glp-1-weight-loss-drugs-is-set-to-surge/index.html) 03.13.26 [**Direct access isn’t a program – it’s market design**](/content/insights/direct-access-isnt-a-program-its-market-design/index.html) Welcome to a direct access marketplace, where incentives are aligned by design so access becomes the default outcome. [Read More](/content/insights/direct-access-isnt-a-program-its-market-design/index.html) 01.28.26 [In the News](/content/news-type/in-the-news/index.html) [**Data shows US advertising spend increasing for pharma manufacturers**](/content/data-shows-us-advertising-spend-increasing-for-pharma-manufacturers/index.html) Even with increased availability, access to GLP-1 therapies can be challenging for employers and healthcare consumers due to… [Read More](/content/data-shows-us-advertising-spend-increasing-for-pharma-manufacturers/index.html) 01.12.26 [In the News](/content/news-type/in-the-news/index.html) [**Prescryptive and Ilant Health Partner to Deliver Transparent Pricing and Clinical Excellence**](/content/prescryptive-and-ilant-health-partner-to-deliver-transparent-pricing-and-clinical-excellence/index.html) Access is the new standard – and with partners like Ilant Health, Prescryptive is delivering it. Our collaboration… [Read More](/content/prescryptive-and-ilant-health-partner-to-deliver-transparent-pricing-and-clinical-excellence/index.html) 01.9.26 [Press Release](/content/news-type/press-release/index.html) [**Prescryptive and Ilant Health Expand Employer-Direct Access to Obesity Care and Transparent GLP-1 Access at Scale**](/content/prescryptive-and-ilant-health-expand-employer-direct-access-to-obesity-care-and-transparent-glp-1-access-at-scale/index.html) Redmond, WA – Friday, Jan. 9, 2026 — Prescryptive and Ilant Health today announced a collaboration to help… [Read More](/content/prescryptive-and-ilant-health-expand-employer-direct-access-to-obesity-care-and-transparent-glp-1-access-at-scale/index.html) 12.10.25 [**Redefining drug access: How the Direct Marketplace helps transform sustainable drug pricing, patient affordability, and innovation**](/content/insights/redefining-drug-access-how-the-direct-marketplace-helps-transform-sustainable-drug-pricing-patient-affordability-and-innovation/index.html) For decades, the U.S. drug distribution model has depended on a complex web of intermediaries — pharmacy benefit… [Read More](/content/insights/redefining-drug-access-how-the-direct-marketplace-helps-transform-sustainable-drug-pricing-patient-affordability-and-innovation/index.html) As Seen In: Drug Topics 11.17.25 [In the News](/content/news-type/in-the-news/index.html) [**A broker’s guide to breaking the rebate cycle**](/content/a-brokers-guide-to-breaking-the-rebate-cycle/index.html) Prescription drug costs are among the fastest-growing and most unpredictable healthcare expenses employers face. According to recent data,… [Read More](/content/a-brokers-guide-to-breaking-the-rebate-cycle/index.html) 09.25.25 [In the News](/content/news-type/in-the-news/index.html) [**Navigating GLP-1 access & complexity: 4 key insights**](/content/navigating-glp-1-access-complexity-4-key-insights/index.html) Glucagon-like peptide-1 (GLP-1) therapies are reshaping care for diabetes, obesity, and cardiometabolic health. Yet with their rapid rise… [Read More](/content/navigating-glp-1-access-complexity-4-key-insights/index.html)